H pylori antibiotic resistance:: prevalence, importance, and advances in testing

被引：753

作者：

Mégraud, F ^{[1
]}

机构：

[1] Hop Pellegrin, Bacteriol Lab, F-33076 Bordeaux, France

来源：

GUT | 2004年 / 53卷 / 09期

关键词：

D O I：

10.1136/gut.2003.022111

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

[No abstract available]

引用

页码：1374 / 1384

页数：11

共 151 条

[1]

Alarcón T, 2000, J CLIN MICROBIOL, V38, P923

[2] Clarithromycin resistance among Helicobacter pylori strains isolated from children:: Prevalence and study of mechanism of resistance by PCR-restriction fragment length polymorphism analysis [J].

Alarcón, T ;

Vega, AE ;

Domingo, D ;

Martínez, MJ ;

López-Brea, M .

JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (01) :486-488

[3]

Aldana LP, 2002, HELICOBACTER, V7, P306

[4]

[Anonymous], 1997, Gastroenterology, V113, pS4

[5]

Bago J, 2002, WIEN KLIN WOCHENSCHR, V114, P448

[6] Ranitidine bismuth citrate with clarithromycin alone or with metronidazole for the eradication of Helicobacter pylori [J].

Bardhan, KD ;

Morton, D ;

Perry, MJ ;

Sanders, DS ;

Morris, P ;

Rowland, A ;

Thompson, M ;

Mitchell, TR ;

Roberts, PM .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2001, 15 (08) :1199-1204

[7] The HOMER study:: The effect of increasing the dose of metronidazole when given with omeprazole and amoxicillin to cure Helicobacter pylori infection [J].

Bardhan, KD ;

Bayerdörffer, E ;

Van Zanten, SJOV ;

Lind, T ;

Mégraud, F ;

Delchier, JC ;

Hellblom, M ;

Stubberöd, A ;

Burman, CF ;

Gromark, PO ;

Zeijlon, L .

HELICOBACTER, 2000, 5 (04) :196-201

[8]

Bayerdörffer E, 1999, ALIMENT PHARM THERAP, V13, P1639

[9]

Bazzoli F, 1998, ALIMENT PHARM THERAP, V12, P439

[10]

Birac C, 1999, GUT, V45, pA107

← 1 2 3 4 5 6 7 8 9 10 →